Skip to main
  1. Stocks
  2. Twist Bioscience Corp
  3. Forecast
TWST

TWST Stock Forecast & Price Target

TWST Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 42%
Hold 25%
Sell 0%
Strong Sell 8%

Bulls say

Twist Bioscience is well positioned because its silicon-based DNA synthesis platform lowers cost and increases throughput, addressing a core bottleneck in synthetic biology while supporting both NGS and DNA synthesis demand. The company is seeing strong AI-driven orders that are expected to reach triple-digits % in FY26, with at least ~$50M versus ~$25M in FY25, reinforcing a durable multi-year tailwind rather than a short-lived spike. Beyond AI, NGS remains a major growth engine expected to stay above 20% growth by FQ4 and contribute to FY26 revenue guidance of $446M, with expanding gross margins and a path to Adj. EBITDA breakeven by FQ4 adding further earnings leverage.

Bears say

Twist Bioscience is viewed negatively because it trades at a significant premium in a highly competitive life sciences tools market where incumbents like Danaher, Agilent, and Roche can bundle offerings and pressure pricing, limiting the company’s ability to sustain outsized margins. Its growth thesis also depends on AI-driven demand and NGS momentum, but the August 2026 stock surge was only a benchmark study, not a strategic partnership, and there is no clear evidence that NVO needs to use TWST alongside Claude Science. With profitability still dependent on gross margin improvement and disciplined expense control, any slower-than-expected adoption, weaker demand, or added investment could delay breakeven and weigh on valuation.

TWST has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 42% recommend Buy, 25% suggest Holding, 0% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of Twist Bioscience Corp and is not a guaranteed prediction by Public.com or investment advice.

TWST Analyst Forecast & Price Prediction

Get the latest TWST stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in TWST

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Twist Bioscience Corp (TWST) Forecast

Analysts have given TWST a Buy based on their latest research and market trends.

According to 12 analysts, TWST has a Buy consensus rating as of Oct 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $143.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $143.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Twist Bioscience Corp (TWST)


TWST Analyst Forecast & Price Prediction

Get the latest TWST stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in TWST

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover TWST stock data and trends